Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-25-195035
Filing Date
2025-09-03
Accepted
2025-09-03 17:00:07
Documents
2
Period of Report
2025-09-03

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1602
2 EX-24 kymr-ex24.htm EX-24 9699
  Complete submission text file 0001193125-25-195035.txt   12716
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Adams Brian (Reporting) CIK: 0001636994 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39460 | Film No.: 251290710

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)